REGISTERED
on 28 May 2024
Last Applicant/ Owned by
140 First Street
Cambridge
MA
02141
Serial Number
97462190 filed on 16th Jun 2022
Registration Number
7402892 registered on 28th May 2024
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RING THERAPEUTICS
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal Read More
Classification Information
Class [005]
Pharmaceutical Products
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
First Use Date in General
11th Oct 2023
First Use Date in Commerce
11th Oct 2023
Mark Details
Serial Number
No 97462190
Mark Type
No Service/Collective Mark
Attorney Docket Number
No V03222000301
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 28th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 25th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 25th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 29th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 07th Mar 2024 | TEAS STATEMENT OF USE RECEIVED |
| 07th Mar 2024 | USE AMENDMENT FILED |
| 26th Dec 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 26th Dec 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |